Everest Medicines Starts Operations at Its mRNA Vaccine Manufacturing Facility, Accelerating the Evolution to a Fully Integrated Biopharma
–Everest has a complete pharmaceutical and vaccine value chain, from discovery, clinical development, manufacturing and commercialization– — Locates the company’s mRNA vaccine production and helps meet urgent needs China and global demand for innovative vaccines and medicines– SHANGHAI, December 27, 2022 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”), a biopharmaceutical company focused on the development, …